New drugs can be developed from old ones. This revolutionary pharmacological approach was confirmed by a study published today in Nature Communications that was conducted by two major research centers of the University of ...
Nov 18, 2019
0
4
One of the biggest challenges to the development of medical treatments for cancer is the fact that there is no single kind of cancer. Cancers derive from many kinds of cells and tissues, and each have their own characteristics, ...
Sep 28, 2020
0
24
New research by Swansea University academics has shown that harnessing metabolism at a cellular level may help to relieve or heal a range of disorders.
May 7, 2019
0
2
Slow-wave sleep, or 'deep sleep', is intimately involved in the complex control of the onset of puberty, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology and ...
Sep 13, 2012
0
0
Intravenous treatment with omega-3 fatty acids in elderly hospitalized patients in intensive care due to COVID-19 seems to have positive effects on the ability of the immune system to cope with the virus, according to a study ...
Sep 29, 2022
0
10
About a quarter of all adults have metabolic syndrome; a syndrome whose most well-known symptoms are obesity, high blood pressure and poor cholesterol levels. Eating differently and exercising more is the general advice for ...
Dec 21, 2018
0
2
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum ...
Sep 23, 2013
0
0
An international team of researchers, including an investigator with the Virginia Bioinformatics Institute at Virginia Tech, has produced what may be the most comprehensive computer model of human metabolism yet developed.
Mar 4, 2013
0
0
Proteins responsible for controlling levels of iron in the body also play an important role in combatting infection, according to a study published today in Cell Host & Microbe.
Jul 16, 2015
0
15
In a recent randomized clinical trial of hospitalized patients with COVID-19 and cardio-metabolic risk factors, the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin did not significantly reduce patients' risk ...
Apr 28, 2022
0
3
